IVIG Therapy: In-home therapy for Desensitization and Antibody Mediated Rejection patients by American Outcomes ManagementAmerican Outcomes Management (AOM) has valuable experience using IVIG in the treatment of Transplant Desensitization and Antibody Mediated Rejection (AMR) in lung, pancreas, intestine, heart and kidney patients. AOM works in conjunction with the Miami Transplant Institute, Columbia University Medical Center, Mount Sinai RMTI Transplantation Institute, Montefiore Einstein Center for Transplantation and many other transplant centers in the United States. AOM has developed protocols for IVIG infusions that focus on the reduction of adverse effects associated when using large doses of IVIG. The AOM IVIG formulary includes all of the IVIG brands manufactured which allows us to meet the specific medication needs of the transplant teams that we work with. AOM continues to raise the bar on patient-centered care and is the leader in providing IVIG therapy and services for both Ig Desensitization and Antibody Medicated Rejection patients. AOM has the knowledge and experience to support your specialized needs. For more information on desensitization and AMR treatment, please contact us at 1-800-746-9089. Press zero to speak to an AOM staff member 9am-5pm, Monday through Friday. We will be happy to answer all of your questions about AOM and our desensitization and AMR treatment. If you are a physician and would like to refer a patient to AOM for desensitization treatment, please contact us at 1-800-746-9089. |